tiprankstipranks
Trending News
More News >
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Compare Summit Therapeutics (SMMT) vs. Competitors

Compare
1,851 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$17.65
$13.14B
-14.21
6.01%
9 Buy
3 Hold
1 Sell
Moderate Buy
Incyte
$105.95
$20.80B
17.77
47.30%
9 Buy
9 Hold
1 Sell
Moderate Buy
United Therapeutics
$475.73
$20.48B
18.03
30.44%
6 Buy
3 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$217.32
$13.28B
-51.17
65.17%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$35.34
$21.59B
14.89
63.31%
4 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$109.12
$26.24B
-41.48
-2.94%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
17.65
-0.54
-2.97%
INCY
Incyte
105.95
33.48
46.20%
UTHR
United Therapeutics
475.73
109.34
29.84%
ASND
Ascendis Pharma
217.32
85.70
65.11%
GMAB
Genmab
35.34
14.12
66.54%
BNTX
BioNTech SE
109.12
-3.64
-3.23%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts